QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 celularity-announces-publication-of-its-phase-2-study-on-pda-002-demonstrating-safety-and-efficacy-in-treating-complex-diabetic-wounds

Celularity Inc. (NASDAQ:CELU) ("Celularity"), a regenerative and cellular medicine company addressing age-related and d...

Core News & Articles

Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The ...

 wbb-securities-upgrades-celularity-to-buy-maintains-price-target-to-6

WBB Securities analyst Steve Brozak upgrades Celularity (NASDAQ:CELU) from Hold to Buy and maintains the price target from $...

 wbb-securities-initiates-coverage-on-celularity-with-speculative-buy-rating-announces-price-target-of-6

WBB Securities analyst Steve Brozak initiates coverage on Celularity (NASDAQ:CELU) with a Speculative Buy rating and announc...

 celularity-inc-surges-over-8-pre-market-amid-florida-stem-cell-policy-new-partnership-boost

Celularity Inc. (NASDAQ: CELU) saw an 8.04% rise in stock value during pre-market hours on Tuesday due to a regulatory change.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION